Insider Trading & SAST disclosures for Colinz Laboratories
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
VIJAYA MANI in Colinz Laboratories where Acquisition of 867,750
Equity Shares done at an average price of Rs. 45.8
was reported to the exchange on Dec. 18, 2025.
There were no SAST disclosures made for Colinz Laboratories
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
VIJAYA MANI
|
Promoter |
Acquisition |
18 Dec 2025 |
867,750 |
1,248,500
(49.56%)
|
34.45%
|
45.8 |
39,786,337
|
11 Dec 2025
11 Dec 2025 |
Insider Trading |
Equity Shares |
Off Market |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.